Cargando…

Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus Thrombosis

Cerebral venous sinus thrombosis (CVST), accounting for less than 1% of stroke cases, is characterized by various causes, heterogeneous clinical presentation and different outcome. The plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms has been found to be associated with CVST. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gogu, Anca Elena, Motoc, Andrei Gheorghe, Stroe, Alina Zorina, Docu Axelerad, Any, Docu Axelerad, Daniel, Petrica, Ligia, Jianu, Dragos Catalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146064/ https://www.ncbi.nlm.nih.gov/pubmed/33922851 http://dx.doi.org/10.3390/metabo11050266

Ejemplares similares

MTHFR Gene Polymorphisms and Cardiovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus Thrombosis
por: Gogu, Anca Elena, et al.
Publicado: (2020)

Tolosa–Hunt Syndrome and Hemorrhagic Encephalitis Presenting in a Patient after COVID-19 Vaccination Followed by COVID-19 Infection
por: Gogu, Anca Elena, et al.
Publicado: (2022)

Clinical Spectrum and Neuroimagistic Features in Hospitalized Patients with Neurological Disorders and Concomitant Coronavirus-19 Infection
por: Gogu, Anca Elena, et al.
Publicado: (2021)

Back Pain in Rare Diseases: A Comparison of Neck and Back Pain between Spinal Cord Ischemia and Spinal Dural Arteriovenous Fistula
por: Gogu, Anca Elena, et al.
Publicado: (2020)

Respiratory Dysfunctions in Parkinson’s Disease Patients
por: Docu Axelerad, Any, et al.
Publicado: (2021)

Narrative Review of New Insight into the Influence of the COVID-19 Pandemic on Cardiovascular Care
por: Axelerad, Any, et al.
Publicado: (2022)

Diagnosis and Management of Mixed Transcortical Aphasia Due to Multiple Predisposing Factors, including Postpartum and Severe Inherited Thrombophilia, Affecting Multiple Cerebral Venous and Dural Sinus Thrombosis: Case Report and Literature Review
por: Jianu, Dragoș Cătălin, et al.
Publicado: (2021)

An Integrated Approach on the Diagnosis of Cerebral Veins and Dural Sinuses Thrombosis (a Narrative Review)
por: Jianu, Dragos Catalin, et al.
Publicado: (2022)

Ultrasound Technologies and the Diagnosis of Giant Cell Arteritis
por: Jianu, Dragoș Cătălin, et al.
Publicado: (2021)

Case Reports of Pregnancy-Related Cerebral Venous Thrombosis in the Neurology Department of the Emergency Clinical Hospital in Constanta
por: Axelerad, Any Docu, et al.
Publicado: (2022)

Impact of SARS-CoV-2 Infection in Patients with Neurological Pathology
por: Axelerad, Any Docu, et al.
Publicado: (2022)

Benefits of Tango Therapy in Alleviating the Motor and Non-Motor Symptoms of Parkinson’s Disease Patients—A Narrative Review
por: Docu Axelerad, Any, et al.
Publicado: (2022)

The Clinical Profile of Cat-Scratch Disease’s Neuro-Ophthalmological Effects
por: Jurja, Sanda, et al.
Publicado: (2022)

Diagnosis and Management of Cerebral Venous Thrombosis Due to Polycythemia Vera and Genetic Thrombophilia: Case Report and Literature Review
por: Jianu, Dragos Catalin, et al.
Publicado: (2023)

EHMTI-0328. Comparative evaluation of pregabalin, gabapentin, carbamazepine and topiramat in migraine
por: Axelerad, A Docu, et al.
Publicado: (2014)

Three cases of neurosyphilis diagnosed in the 21st century: A case report
por: Codreanu Balaban, Ramona Andreea, et al.
Publicado: (2023)

Aphasic Syndromes in Cerebral Venous and Dural Sinuses Thrombosis—A Review of the Literature
por: Munteanu, Georgiana, et al.
Publicado: (2022)

Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review
por: Sirbu, Carmen Adella, et al.
Publicado: (2020)

MTHFR Gene Polymorphisms Prevalence and Cardiovascular Risk Factors Involved in Cardioembolic Stroke Type and Severity
por: Chita, Dana Simona, et al.
Publicado: (2020)

Narrative Review Concerning the Clinical Spectrum of Ophthalmological Impairments in Parkinson’s Disease
por: Stuparu, Alina Zorina, et al.
Publicado: (2023)

MRI Evolution of a Patient with Viral Tick-Borne Encephalitis and Polymorphic Seizures
por: Sirbu, Carmen Adella, et al.
Publicado: (2022)

Management of an old woman with cavernous sinus thrombosis with two different mechanisms: case report and review of the literature
por: Dan, Traian Flavius, et al.
Publicado: (2020)

Aggressiveness of Grade 4 Gliomas of Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

Infectious Microorganisms Seen as Etiologic Agents in Parkinson’s Disease
por: Zorina, Stuparu Alina, et al.
Publicado: (2023)

Clinical Characteristics and Laboratory Findings in Children with Multisystem Inflammatory Syndrome (MIS-C)—A Retrospective Study of a Tertiary Care Center from Constanta, Romania
por: Mihai, Cristina Maria, et al.
Publicado: (2023)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
por: Alotaibi, Fahad T., et al.
Publicado: (2019)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
por: White, Marquitta J., et al.
Publicado: (2015)

High-Resolution Tandem Mass Spectrometry Identifies a Particular Ganglioside Pattern in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus Patients
por: Suteanu-Simulescu, Anca, et al.
Publicado: (2022)

Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study
por: Vlad, Adrian, et al.
Publicado: (2016)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
por: Pierga, J. Y., et al.
Publicado: (1997)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Criteria and Search for Specific Assays for Active Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma
por: Kluft, C.
Publicado: (2000)

Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice
por: Kenny, Susan, et al.
Publicado: (2013)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix
Publicado: (1991)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qjsr62ghumtljhr1phgc5tk917